ZBIO
Zenas BioPharma, Inc.
26.20$
-6.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -148.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.4% | +10.0% | +6.1% | +2.9% | -8.3% | -30.3% | -4,113.0% | – | -9.1% | -40.0% | -33.3% | – | |
| – | +13.0% | -16.6% | +62.2% | +85.1% | +93.3% | -2.0% | +12.2% | +21.4% | +3.3% | +21.3% | -6.3% | – | |
| – | – | -9.3% | -24.9% | -11.9% | +95.1% | -199.9% | – | -171.0% | – | -218.6% | – | – | |
| – | – | +29.4% | +59.1% | -100.0% | – | -75.7% | -100.0% | – | +500.0% | -100.0% | +1,499,900.0% | – | |
| – | – | +29.4% | +59.1% | +76,357.1% | -86.0% | +2,209.9% | +30.2% | – | -333.2% | – | -1,010.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -89.1% | – | |
| – | -99.8% | -1,328.0% | – | +31.6% | -99.2% | -94.7% | +1,639.4% | +4,117.0% | +94.0% | +207.8% | -90.3% | – | |
| – | -129.8% | – | – | +20.0% | -122.9% | – | – | – | -106.9% | – | -177.9% | – | |
| – | -148.4% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.